Hydroxyzine Pamoate
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
76420-920 -
Package NDC
76420-920-01 -
Package NDC
76420-920-05 -
Package NDC
76420-920-30 -
Package NDC
76420-920-60 -
Package NDC
76420-920-90 -
Application number
ANDA088496 -
SPL ID
2e63fa75-efcf-d9ee-e063-6394a90ab2d0 -
SPL set ID
82187031-779e-47bc-943c-eb1a1ef30a7a -
UNII
M20215MUFR -
RxCUI
995232 -
RxCUI
995253 -
RxCUI
995278
What the source publishes
- Labeler
- Asclemed USA, Inc.
- Active ingredients
- Hydroxyzine Pamoate
- Form
- CAPSULE
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Hydroxyzine Pamoate",
"splId": "2e63fa75-efcf-d9ee-e063-6394a90ab2d0",
"labels": [
{
"setId": "82187031-779e-47bc-943c-eb1a1ef30a7a",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=82187031-779e-47bc-943c-eb1a1ef30a7a",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=82187031-779e-47bc-943c-eb1a1ef30a7a"
}
],
"routes": [
"ORAL"
],
"labeler": "Asclemed USA, Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "100 CAPSULE in 1 BOTTLE (76420-920-01)",
"package_ndc": "76420-920-01",
"identifierStatus": "well-formed",
"marketing_start_date": "20250218"
},
{
"sample": false,
"description": "500 CAPSULE in 1 BOTTLE (76420-920-05)",
"package_ndc": "76420-920-05",
"identifierStatus": "well-formed",
"marketing_start_date": "20250218"
},
{
"sample": false,
"description": "30 CAPSULE in 1 BOTTLE (76420-920-30)",
"package_ndc": "76420-920-30",
"identifierStatus": "well-formed",
"marketing_start_date": "20250218"
},
{
"sample": false,
"description": "60 CAPSULE in 1 BOTTLE (76420-920-60)",
"package_ndc": "76420-920-60",
"identifierStatus": "well-formed",
"marketing_start_date": "20250218"
},
{
"sample": false,
"description": "90 CAPSULE in 1 BOTTLE (76420-920-90)",
"package_ndc": "76420-920-90",
"identifierStatus": "well-formed",
"marketing_start_date": "20250218"
}
],
"productId": "76420-920_2e63fa75-efcf-d9ee-e063-6394a90ab2d0",
"useDomain": "unknown",
"dosageForm": "CAPSULE",
"productNdc": "76420-920",
"deaSchedule": null,
"genericName": "Hydroxyzine Pamoate",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "HYDROXYZINE PAMOATE",
"strength": "25 mg/1"
}
],
"applicationNumber": "ANDA088496",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "19840701",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"unii": [
"M20215MUFR"
],
"rxcui": [
"995232",
"995253",
"995278"
],
"spl_set_id": [
"82187031-779e-47bc-943c-eb1a1ef30a7a"
],
"manufacturer_name": [
"Asclemed USA, Inc."
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:76420-920_2e63fa75-efcf-d9ee-e063-6394a90ab2d0"